• Big data and machine learning are booming also in healthcare, where it enables precision medicine and population health platform services.
• Sema4 Holdings has amassed huge amounts of medical data and a sophisticated platform in order to extract valuable insight from these for health systems, pharma companies and individuals.
• Their recent acquisition significantly adds to their data trove, lifts gross margins and enables cost and revenue synergies.
• The company won’t be cash flow positive before the end of 2025, additional financing needs are certainly not imminent but arrive in a couple of years.
• Looking for more investing ideas like this one? Get them exclusively at SHU Growth Portfolio. Learn More »

Sema4 Stock: Big Data For Precision Medicine Solutions